Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Pb Multiple | 6.6x - 7.3x | 6.9x |
| Historical Pb Multiple | 5.3x - 102.5x | 14.6x |
| Fair Value | C$0.17 - C$0.18 | C$0.18 |
| Upside | -7.3% - 2.4% | -2.5% |
| Benchmarks | - | Full Ticker |
| Target Group Inc. | - | OTCPK:CBDY |
| Cronos Group Inc. | - | TSX:CRON |
| Body and Mind Inc. | - | CNSX:BAMM |
| Simply Better Brands Corp. | - | TSXV:SBBC |
| Medexus Pharmaceuticals Inc. | - | TSX:MDP |
| InnoCan Pharma Corporation | - | CNSX:INNO |
| Select Price / Book Ratio | ||||||||
| Benchmark Companies | ||||||||
| CBDY | CRON | BAMM | SBBC | MDP | INNO | |||
| OTCPK:CBDY | TSX:CRON | CNSX:BAMM | TSXV:SBBC | TSX:MDP | CNSX:INNO | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | NM- | -48.8% | NM- | NM- | NM- | NM- | ||
| 3Y CAGR | -16.2% | NM- | NM- | NM- | NM- | NM- | ||
| Latest Twelve Months | 149.6% | 158.8% | 21.7% | -115.6% | -39.4% | 61.0% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | -7982.5% | 61.8% | -77.8% | -24.2% | -8.6% | -10780.0% | ||
| Prior Fiscal Year | -8.7% | -80.1% | -123.5% | -18.9% | 1.1% | -147.1% | ||
| Latest Fiscal Year | 2.4% | 34.9% | -91.1% | -30.4% | -0.2% | -34.4% | ||
| Latest Twelve Months | 2.4% | 34.9% | -98.3% | -26.0% | 3.3% | -9.0% | ||
| Return on Equity | ||||||||
| 5 Year Average Margin | -290.9% | -2.6% | -426.5% | -195.0% | -35.9% | -363.4% | ||
| Prior Fiscal Year | NM | -6.2% | -131.3% | -196.1% | 6.1% | -89.5% | ||
| Latest Twelve Months | NM | 3.8% | -6049.5% | -277.1% | 11.4% | -39.6% | ||
| Next Fiscal Year | -3.4% | -7.1% | #NUM! | -0.6% | 18.9% | #NUM! | ||
| Two Fiscal Years Forward | -7.3% | -7.1% | 100.6% | -5098.4% | 48.6% | 1055.9% | ||
| Current Trading Multiples | ||||||||
| Price / LTM Sales | 0.2x | 5.8x | 0.1x | 0.8x | 0.5x | 1.3x | ||
| Price / LTM EPS | 7.3x | 16.5x | -0.1x | -3.2x | 14.8x | -20.2x | ||
| Price / Book | -0.2x | 0.6x | -0.1x | 11.6x | 1.6x | 7.2x | ||
| Price / Fwd Book | -0.2x | 0.7x | -0.3x | -20.3x | 3.0x | 7.1x | ||
| Low | Mid | High | ||||||
| Benchmark P/B Ratio | -0.2x | 0.6x | 11.6x | |||||
| Historical P/B Ratio | 5.3x | 14.6x | 102.5x | |||||
| Selected P/B Multiple | 6.6x | 6.9x | 7.3x | |||||
| (x) Book Value | 5 | 5 | 5 | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | CBDY | CRON | BAMM | SBBC | MDP | INNO | |
| Value of Common Equity | 1 | 674 | 3 | 73 | 52 | 37 | |
| (/) Shares Outstanding | 617.0 | 382.5 | 149.0 | 107.2 | 32.3 | 290.1 | |
| Implied Stock Price | 0.00 | 1.76 | 0.02 | 0.68 | 1.62 | 0.13 | |
| FX Conversion Rate to Trading Currency | 1.00 | 0.70 | 0.70 | 0.70 | 0.70 | 0.70 | |
| Implied Stock Price (Trading Cur) | 0.00 | 2.50 | 0.03 | 0.97 | 2.30 | 0.18 | |
| Trading Currency | USD | CAD | CAD | CAD | CAD | CAD | |
| FX Rate to Reporting Currency | 1.00 | 0.70 | 0.70 | 0.70 | 0.70 | 0.70 | |